Celltrion Inc., a major South Korean biopharmaceutical firm, said Friday its new biosimilar for an autoimmune disease treatment has received approval from the U.S. Food and Drug Administration (FDA).
East-West Shrine Bowl kicks off Thursday at AT&T Stadium. The annual meeting of some of the best college football players in ...
The East West Shrine Bowl in Arlington has a recognizable logo showing a football player and a little girl that goes back ...
Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most ...
A recall which was issued across nine states has now been given the highest risk classification by the federal agency.